SCHEMBL13044409

SCHEMBL13044409

Cc1cc(Br)c(O)c(-c2cc(F)cc(F)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
F2 P00734 2/20 0.36
F10 P00742 2/20 0.36
PLG P00747 2/20 0.36
PLAU P00749 2/20 0.36
PLAT P00750 2/20 0.36
PRSS1 P07477 2/20 0.36
PTGS2 P35354 2/20 0.35
PTGS1 P23219 1/20 0.35
CA1 P00915 2/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18171930 0.84 MEN1 (0.43) GABRA1GABRB1GABRA2GABRB2F2
SCHEMBL880200 0.80 GABRA1 (0.56) GABRA1GABRB1GABRA2GABRB2F2
SCHEMBL24910068 0.79 TTR (0.51) MEN1KMT2A
SCHEMBL13044416 0.77 RAPGEF4 (0.37) GABRA1GABRB1GABRA2GABRB2F2
SCHEMBL5086984 0.76 CRHBP (0.53) F2F10PLGPLAUPLAT
SCHEMBL24909370 0.75 TTR (0.60) GABRA1GABRB1GABRA2GABRB2MEN1
SCHEMBL24086757 0.74 GABRA1 (0.38) GABRA1GABRB1GABRA2GABRB2F2
SCHEMBL1502445 0.72 CYP3A4 (0.58) GABRA1GABRB1GABRA2GABRB2PTGS2
SCHEMBL24086818 0.71 MAPT (0.40) GABRA1GABRB1GABRA2GABRB2F2
SCHEMBL25403070 0.71 GABRA1 (0.39) GABRA1GABRB1GABRA2GABRB2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501840-B1 BRIDGED BI-AROMATIC LIGANDS, COMPLEXES, CATALYSTS, PROCESSES FOR POLYMERIZING AND POLYMERS THEREFROM SYMYX SOLUTIONS INC (US) 2010-12-22 EP disclosed
US-7659415-B2 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom SYMYX SOLUTIONS, INC. (US) 2010-02-09 US disclosed
US-7659415-B2 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom SYMYX SOLUTIONS, INC. (US) 2010-02-09 US disclosed
US-20080269470-A1 Bridged Bi-Aromatic Ligands, Catalysts, Processes For Polymerizing And Polymers Therefrom SYMYX TECHNOLOGIES, INC. (US) 2008-10-30 US disclosed
US-20080269470-A1 Bridged Bi-Aromatic Ligands, Catalysts, Processes For Polymerizing And Polymers Therefrom SYMYX TECHNOLOGIES, INC. (US) 2008-10-30 US disclosed
US-7241715-B2 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom SYMYX TECHNOLOGIES, INC. (US) 2007-07-10 US disclosed
US-7241715-B2 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom SYMYX TECHNOLOGIES, INC. (US) 2007-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269470-A1 Bridged Bi-Aromatic Ligands, Catalysts, Processes For Polymerizing And Polymers Therefrom WEE1, WASF2, WEE2 GABRA1 392/4885GABRB1 352/4885GABRA2 467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.